Literature DB >> 4852070

Flux of free fatty acids among host tissues, ascites fluid, and Ehrlich ascites carcinoma cells.

P Mermier, N Baker.   

Abstract

The role of plasma free fatty acids (FFA) in the transport of fatty acids from host tissues to Ehrlich ascites carcinoma in mice was studied. [9,10-(3)H] Palmitate complexed to mouse serum (albumin) was injected either intraperitoneally or intravenously into unanesthetized tumor-bearing mice. The incorporation of radioactivity into tumor extracellular fluid FFA, tumor cell FFA, neutral lipid, phospholipid, water-soluble material in cells and fluid, plasma FFA, host carcass total lipid fatty acids, and water-soluble (i.e., nonlipid) material was measured. In addition, the quantity of fatty acid in each of the above lipid fractions was determined. The data were analyzed by multicompartmental analysis (SAAM) using a digital computer, and fractional rate constants of FA movement within and out of the host-tumor system were calculated. These rate constants and pool size measurements were used to estimate the corresponding fluxes. Although FFA in the tumor's extracellular fluid were replaced rapidly, almost none of the newly formed fluid FFA was derived from plasma FFA. Moreover, the transfer of FFA from the tumor extracellular fluid FFA to plasma FFA was virtually negligible. We suggest that the net amount of FFA required to replace the fluid FFA utilized for tumor energy and growth may be derived from direct transfer of FFA from host tissues to the ascitic fluid and that plasma FFA is not an intermediate in this transport process. The transport of FFA from the host to tumor cell lipids through the tumor extracellular fluid was about 26-fold greater than that required to account for net lipid accumulation during growth.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4852070

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  14 in total

1.  Tumor extracellular triglycerides in mice during growth of Ehrlich ascites carcinoma.

Authors:  R Kannan; N Baker
Journal:  Lipids       Date:  1975-12       Impact factor: 1.880

2.  Blood sampling techniques for studying rapidly turning over metabolic fuels in mice.

Authors:  N Baker; D Morris; C Sandborg
Journal:  Lipids       Date:  1976-11       Impact factor: 1.880

Review 3.  Lipids changes in liver cancer.

Authors:  Jing-Ting Jiang; Ning Xu; Xiao-Ying Zhang; Chang-Ping Wu
Journal:  J Zhejiang Univ Sci B       Date:  2007-06       Impact factor: 3.066

Review 4.  Adipose tissue and adipocytes support tumorigenesis and metastasis.

Authors:  Kristin M Nieman; Iris L Romero; Bennett Van Houten; Ernst Lengyel
Journal:  Biochim Biophys Acta       Date:  2013-03-14

5.  Regulation of fatty acid biosynthesis in Ehrlich cells by ascites tumor plasma lipoproteins.

Authors:  R McGee; D E Brenneman; A A Spector
Journal:  Lipids       Date:  1977-01       Impact factor: 1.880

6.  Hypertriglyceridemia in Ehrlich ascites carcinomatous mice: tumor and mouse strain differences.

Authors:  R Kannan; N Baker
Journal:  Lipids       Date:  1977-02       Impact factor: 1.880

7.  Essential and nonessential fatty acid oxidation in mice bearing Ehrlich ascites carcinoma.

Authors:  M Ookhtens; N Baker
Journal:  Lipids       Date:  1982-02       Impact factor: 1.880

Review 8.  Influence of liver cancer on lipid and lipoprotein metabolism.

Authors:  Jingting Jiang; Peter Nilsson-Ehle; Ning Xu
Journal:  Lipids Health Dis       Date:  2006-03-03       Impact factor: 3.876

9.  Uptake of plasma lipids by tissue-isolated hepatomas 7288CTC and 7777 in vivo.

Authors:  L A Sauer; R T Dauchy
Journal:  Br J Cancer       Date:  1992-08       Impact factor: 7.640

10.  Effect of the lipid-lowering agent bezafibrate on tumour growth rate in vivo.

Authors:  H D Mulligan; M J Tisdale
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.